A multi-centre evaluation of the intra-assay and inter-assay variation of commercial and in-house anti-cardiolipin antibody assays

Pathology

Volumn 36, Issue 2, 2004, Pages 182-192

  Wong, Richard C W ^a,m   Favaloro, Emmanuel J ^b   Pollock, Wendy ^c   Wilson, Robert J ^a   Hendle, Michelle J ^d   Adelstein, Stephen ^e   Baumgart, Karl ^f   Homes, Paul ^g   Smith, Stuart ^h   Steele, Richard H ^i,l   Sturgess, Allan ^j   Gillis, David ^k  

^a QUEENSLAND HEALTH   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

^c GRIBBLES PATHOLOGY   (Australia)

^d QML Pathology   (Australia)

^e ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^f DOUGLASS HANLY MOIR PATHOLOGY   (Australia)

^g WESTERN DIAGNOSTIC PATHOLOGY   (Australia)

^h CANTERBURY DISTRICT HEALTH BOARD   (New Zealand)

ⁱ LIVERPOOL HOSPITAL   (Australia)

^j ST GEORGE HOSPITAL   (Australia)

^k INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^l WELLINGTON HOSPITAL   (New Zealand)

^m PRINCESS ALEXANDRA HOSPITAL   (Australia)

more..

Author keywords

Anti cardiolipin; Antibody; Calibrator; Coefficient of variation; Commercial; Control; ELISA; IgG; IgM; Inter assay; Intra assay

Indexed keywords

CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ACCURACY; ADULT; ARTICLE; CALIBRATOR; COMPARATIVE STUDY; CONSENSUS; CONTROLLED STUDY; EVALUATION; FEMALE; HUMAN; IMMUNOASSAY; MULTICENTER STUDY; PRACTICE GUIDELINE; QUANTITATIVE ASSAY;

EID: 11144353893     PISSN: 00313025     EISSN: None     Source Type: Journal    
DOI: 10.1080/00313020410001672037     Document Type: Article

References (16)

1. Harris EN, Pierangeli SS. Revisiting the anticardiolipin test and its standardization. Lupus 2002; 11: 269-75.
2. Favaloro EJ, Silvestrini R. Assessing the usefulness of anticardiolipin antibody assays: a cautious approach is suggested by high variation and limited consensus in multilaboratory testing. Am J Clin Pathol 2002; 118: 548-57.
3. Robert JM, Macara LM, Chalmers EA, Smith GC. Inter-assay variation in antiphospholipid antibody testing. BJOG 2002; 109: 348-9.
4. Tincani A, Allegri F, Sanmarco M, et al. Anticardiolipin antibody assay: a methodological analysis for a better consensus in routine determinations - a cooperative project of the European Antiphospholipid Forum. Thromb Haemost 2001; 86: 575-83.
5. Fontaine M, Homburger HA, Nichols WL. Persistent problems with standardization of immunoassays for anti-cardiolipin antibodies. Thromb Haemost 2001; 86: 1123-4.
6. Favaloro EJ, Silvestrini R, Mohammed A. Clinical utility of anticardiolipin antibody assays: high inter-laboratory variation and limited consensus by participants of external quality assurance programs signals a cautious approach. Pathology 1999; 31: 142-7.
7. Reber G, Arvieux J, Comby E, et al. Multicenter evaluation of nine commercial kits for the quantitation of anticardiolipin antibodies. The Working Group on Methodologies in Haemostasis from the GEHT (Groupe d'Etudes sur l'Hemostase et la Thrombose). Thromb Haemost 1995; 73: 444-52.
8. Coulam CB, McIntyre JA, Wagenknecht D, Rote N. Interlaboratory inconsistencies in detection of anticardiolipin antibodies. Lancet 1990; 335: 865.
9. Galli M, Luciani D, Bertolini G, Barbui T. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood 2003; 101: 1827-32.
10. Wong RCW, Gillis D, Adelstein S, et al. Consensus guidelines on anti-cardiolipin antibody testing and reporting. Pathology 2004; 36: 63-8.
11. Wong RCW, Wilson RJ, Pollock W, Steele RH, Gillis D. Anti-cardiolipin antibody testing and reporting practices among laboratories participating in a large external Quality Assurance Program. Pathology 2004; 36: 174-181.
12. Wilson WA, Gharavi AE, Koike T, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999; 42: 1309-11.
13. Triplett DA. Antiphospholipid antibodies. Arch Pathol Lab Med 2002; 126: 1424-9.
14. Greaves M, Cohen H, MacHin SJ, Mackie I. Guidelines on the investigation and management of the antiphospholipid syndrome. Br J Haematol 2000; 109: 704-15.
15. Lockshin MD, Sammaritano LR, Schwartzman S. Validation of the Sapporo criteria for antiphospholipid syndrome. Arthritis Rheum 2000; 43: 440-3.
16. Harris EN, Gharavi AE, Patel S, Hughes GRV. Evaluation of the anticardiolipin antibody test: report of an international workshop held April 4 1986. Clin Exp Immunol 1987; 68: 215-22.